These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1772986)

  • 1. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
    Elliott JM; Kent A
    J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
    Cowen PJ; Charig EM; Fraser S; Elliott JM
    J Affect Disord; 1987; 13(1):45-50. PubMed ID: 2959699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-hydroxytryptamine receptor of blood platelets.
    Pletscher A; Affolter H
    J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity.
    Moretti-Rojas I; Ezrailson EG; Birnbaumer L; Entman ML; Garber AJ
    J Biol Chem; 1983 Oct; 258(20):12499-508. PubMed ID: 6313663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
    Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
    Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.
    Laubscher A; Pletscher A; Noll H
    J Pharmacol Exp Ther; 1981 Feb; 216(2):385-9. PubMed ID: 6109775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?
    Graf M; Pletscher A
    Br J Pharmacol; 1979 Apr; 65(4):601-8. PubMed ID: 435685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.
    Erne P; Pletscher A
    Br J Pharmacol; 1985 Feb; 84(2):545-9. PubMed ID: 3156650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists: ketanserin and SCH 23390.
    Killam AL; Cohen ML
    Thromb Res; 1991 Nov; 64(3):331-40. PubMed ID: 1805448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha 1-adrenoceptors and 5-HT2 receptors in serotonin-induced contraction of rat prostate: autoradiographical and functional studies.
    Killam AL; Watts SW; Cohen ML
    Eur J Pharmacol; 1995 Jan; 273(1-2):7-14. PubMed ID: 7737320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
    Unsworth CD; Molinoff PB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.
    Müller-Schweinitzer E; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-induced acute desensitization of serotonin2 receptors in human platelets via a mechanism involving protein kinase C.
    Kagaya A; Mikuni M; Kusumi I; Yamamoto H; Takahashi K
    J Pharmacol Exp Ther; 1990 Oct; 255(1):305-11. PubMed ID: 2213562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.